10q23del antikoerper, ACVRLK3 antikoerper, ALK3 antikoerper, CD292 antikoerper, SKR5 antikoerper, 1110037I22Rik antikoerper, AU045487 antikoerper, BMPR-IA antikoerper, Bmpr antikoerper, BMPR-1 antikoerper, BRK-1 antikoerper, BMPR1A antikoerper, acvrlk3 antikoerper, alk-3 antikoerper, alk3 antikoerper, cd292 antikoerper, skr5 antikoerper, BR1a antikoerper, alk3tr antikoerper, bmpr1a antikoerper, zgc:136731 antikoerper, wu:fe05b06 antikoerper, wu:fe06e10 antikoerper, zgc:92227 antikoerper, bone morphogenetic protein receptor type 1A antikoerper, bone morphogenetic protein receptor, type 1A antikoerper, bone morphogenetic protein receptor type 1A S homeolog antikoerper, bone morphogenetic protein receptor, type IAa antikoerper, bone morphogenetic protein receptor, type IAb antikoerper, BMPR1A antikoerper, Bmpr1a antikoerper, bmpr1a antikoerper, bmpr1a.S antikoerper, bmpr1aa antikoerper, bmpr1ab antikoerper
Hintergrund
On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for BMP-2 and BMP-4.